Clinical trial

Reactogenicity and Immunogenicity of Vaginal CNgp140

NCT00637962

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-09-01

PhasePHASE1

Study timeline

Study start (unknown)2007-09-01Date precision: month

Registry last updated2011-02-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Acquired Immune Deficiency Syndromeunresolved

Interventions

HIV glycoprotein CN54gp140 (vaccine)BIOLOGICAL

Carbopol 974BIOLOGICAL

Sponsors & collaborators

St George's, University of Londonlead sponsor

Bill and Melinda Gates Foundationcollaborator

York Hospitalscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00637962 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.